Marex Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337K Buy
+1,803
New +$331K ﹤0.01% 819
2026
Q1
Sell
-2,473
Closed -$491K 1245
2025
Q4
$491K Sell
2,473
-527
-18% -$107K ﹤0.01% 569
2025
Q3
$609K Buy
3,000
+1,000
+50% +$177K ﹤0.01% 446
2025
Q2
$352K Hold
2,000
﹤0.01% 422
2025
Q1
$269K Sell
2,000
-19,500
-91% -$2.57M 0.01% 489
2024
Q4
$2.71M Buy
21,500
+17,343
+417% +$2.58M 0.05% 141
2024
Q3
$691K Buy
+4,157
New +$629K 0.02% 257

Other funds holding THC

Marex Group's THC Position: Q2 2026 in Review

Marex Group opened a new position in Tenet Healthcare (THC) in Q2 2026: 1,803 shares worth $337K. The stake represents ﹤0.01% of the portfolio and ranks #819 among its holdings. This is a return to the name: Marex Group previously reported a position in THC as recently as Q4 2025.

Marex Group first reported a position in THC in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.71M in Q4 2024. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Marex Group held 1,803 shares of Tenet Healthcare worth $337K as of Q2 2026.
  • Tenet Healthcare was a new Marex Group position in Q2 2026.
  • Tenet Healthcare made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #819 holding.
  • Marex Group first reported a position in Tenet Healthcare in Q3 2024 and has held it in 7 quarters since.
  • Marex Group's Tenet Healthcare position peaked at $2.71M in Q4 2024.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.